Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Aug
27
2024
 Cannabis Businessman Learns the Perils of the Not-So “Fine Print” – A Sobering Lesson For Us All Bradley Arant Boult Cummings LLP
Aug
26
2024
 2024 Pre-Election Analysis: Health Care Issues Mintz
Aug
26
2024
 China Releases Draft Guidelines for Front-of-Pack Nutrition Labeling Keller and Heckman LLP
Aug
26
2024
 The Bright Side of the Road: FDA Decision on MDMA Leaves Psychedelic Therapy Down, Far From Out Bradley Arant Boult Cummings LLP
Aug
23
2024
 EPA Bans the Use of DCPA Norris McLaughlin P.A.
Aug
23
2024
 HHS-OIG Highlights Fraud, Abuse Concerns With Manufacturer Offering Financial Assistance to Treat Infertility Side Effects Barnes & Thornburg LLP
Aug
22
2024
 NASEM Will Hold Virtual Town Hall on September 5 as Part of Its Quadrennial Review of the NNI Bergeson & Campbell, P.C.
Aug
22
2024
 Yes, You Can Patent Food Products! Foley & Lardner LLP
Aug
22
2024
 First EU Application Submitted for Lab-Grown Meat Product as Novel Food Keller and Heckman LLP
Aug
22
2024
 Federal Circuit Finds Prior Sale of Product Made By Secret Process Continues to Bar Patent on Process Post-AIA Barnes & Thornburg LLP
Aug
22
2024
 FDA Posts Discussion Paper on Development of an Enhanced Systematic Process for Its Post-Market Assessment of Chemicals in Food; Comments Due December 6, 2024 Bergeson & Campbell, P.C.
Aug
22
2024
 Patent by Secret Process: Perils of Pre-Patent Profiting McDermott Will & Emery
Aug
21
2024
 CMS Finalizes Transitional Coverage for Emerging Technologies (TCET) Coverage Pathway Greenberg Traurig, LLP
Aug
21
2024
 Second Circuit Affirms Win for Defendants in Challenge to Glucosamine Labeling on Federal Preemption Grounds Keller and Heckman LLP
Aug
21
2024
 This Week in 340B: August 13 – 19, 2024 McDermott Will & Emery
Aug
21
2024
 NSF Biomaterials Program Publishes RFI Bergeson & Campbell, P.C.
Aug
20
2024
 Whistleblower Stops Medicaid Fraud at Crossroads Tycko & Zavareei LLP
Aug
20
2024
 July 2024 Bounty Hunter Plaintiff Claims Keller and Heckman LLP
Aug
20
2024
 CMS 2026 IRA Price Negotiations Results Likely to Create Upstream and Downstream Effects Mintz
Aug
20
2024
 FDA Issues Second Edition of Voluntary Sodium Reduction Goals Keller and Heckman LLP
Aug
20
2024
 CMS Releases Final Procedural Notice on Transitional Coverage for Emerging Technology (TCET) McDermott Will & Emery
Aug
19
2024
 CMS Issues Final Notice on Program for Breakthrough Device Reimbursement but Industry Looks to Congress for More Inclusive Solution Mintz
Aug
18
2024
 CNIPA: Frequently Asked Questions re Fees for Open Licensing and Patent Term Compensation Schwegman, Lundberg & Woessner, P.A.
Aug
16
2024
 Real-World Data Back in the Spotlight at FDA McDermott Will & Emery
Aug
16
2024
 CMS Rules Propose Changes Regarding the Medicare Prescription Drug Inflation Rebate Program, Refundable Drugs, Skin Supplements and More; Comments Due September 9 Epstein Becker & Green, P.C.
Aug
16
2024
 What To Expect for the IPO Market in the Second Half of 2024 Foley & Lardner LLP
Aug
15
2024
 UPSIDE Sues Florida Over Cell-Grown Meat Ban Keller and Heckman LLP
Aug
15
2024
 Recent Supreme Court Decisions and the DSCSA Epstein Becker & Green, P.C.
Displaying 309 - 336 of 11741
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins